StonvexLoading…
StonvexStonvexStonvexCore line items from RGNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $170.44M | $83.33M | $90.24M | $112.72M |
Operating Income | $-161.20M | $-233.35M | $-268.13M | $-262.88M |
Net Income | $-193.88M | $-227.10M | $-263.49M | $-280.32M |
EPS (Diluted) | $-3.76 | $-4.59 | $-6.02 | $-6.50 |
Total Assets | $453.03M | $465.99M | $573.97M | $833.27M |
Total Liabilities | $350.30M | $206.34M | $262.23M | $317.07M |
Cash & Equivalents | $34.47M | $57.53M | $34.52M | $96.95M |
Free Cash Flow OCF − CapEx | $-126.38M | $-175.56M | $-228.37M | $-238.21M |
Shares Outstanding | 50.89M | 49.55M | 44.05M | 43.30M |